Skip to main content

Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patients

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Meta-analysis confirms no OS benefit from antiangiogenics for NSCLC patients

User login

Username

Password

Reset your password

Type	Lead	score